4 Results for "

blood-testis barrier

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "blood-testis barrier" in MCE Product Catalog:

Cat. No.: HY-162565
CAS No.: 3086536-23-1
Target:  

STK33 CDK RET

Research Areas:  

Endocrinology

CDD-2807 is an inhibitor for serine/threonine kinase 33 (STK33) with IC50 of 9.2 nM. CDD-2807 exhibits no significant toxicity in mice and can cross the blood-testis barrier without accumulating in the brain. CDD-2807 induces a reversible contraceptive effect and has potential for the development of the male contraceptive .
loading...
    loading...
Cat. No.: HY-157250
CAS No.: 2749517-98-2
Target:  

Apoptosis

Research Areas:  

Endocrinology

BHD is an effective, orally active and reversible contraceptive agent. BHD induces the apoptosis of spermatogenic cells rapidly and disruptes the blood-testis barrier effectively .
loading...
    loading...
Cat. No.: HY-183986
Target:  

RAR/RXR

Research Areas:  

Endocrinology

SR210831C is a highly selective, orally active retinoic acid receptor α (RARα) inhibitor with an IC50 of 0.051 nM. SR210831C suppresses spermatogenesis by reducing sperm count in house mice via acting on the early stages of spermatogenesis, and it does not cross the blood-testis barrier. SR210831C can be used in male contraception research .
loading...
    loading...
Cat. No.: HY-N0391G
CAS No.: 372-75-8
L-Citrulline GMP is an orally active, blood-brain barrier permeable neutral α-amino acid. L-Citrulline GMP inhibits the mitochondrial translocation of Drp1 and maintains mitochondrial homeostasis via a NO-dependent pathway, thereby reducing excessive ROS production. Consequently, L-Citrulline GMP protects sperm DNA integrity, stabilizes the blood-testis barrier and improves semen quality. L-Citrulline GMP can be used in research related to male infertility, mycobacterial infection (tuberculosis) and radiation combined injury .
loading...
    loading...